Company "Synthesis of platinum anti-cancer drugs of new technologies"through the acceptance of Kunming Technology Conference
October 10, 2008, Kunming Science and Technology Bureau expert of my company national SME Technology Innovation Fund project "Synthesis of new platinum anticancer drug technology " for the meeting acceptance. Project leader described the situation of the project is completed, the experts on the acceptance of application materials were reviewed and visited the company's production site, and ultimately agreed to the project through discussions, comprehensive scoring 98.14 points. After the acceptance of enterprise collaboration Kunming Science and Technology will organize the application materials and mail bound to Beijing, the National Innovation Fund Management Committee, the final review.
"Synthesis of new platinum anticancer drug technology " is the August 2005 project of the National SME Technology Innovation Fund, the project is to study Pharmaceutical Co., Ltd. Kunming your existing varieties of cisplatin, carboplatin and other platinum resistance The synthesis of tumor bulk drugs production of new technology and industry research, the project implementation period for the August 2005 ~ August 2008. After three years of implementation, the project undertaker done a lot of work, with cisplatin, carboplatin and other platinum anti-cancer drug synthesis of new materials technology and related industry conducted in-depth and meticulous research, the accumulated sales revenue of 9388.34 Million, a total of 9.5984 million yuan in profits and taxes, $ 10,985,000 total indirect foreign exchange. Made great economic benefits at the same time, the project team members also published four research papers to complete the process study were 9, 3 national invention patent applications (by the notice of acceptance.) Through the implementation of the project, the company built a production capacity of 500 kg, the product quality in line with the Chinese Pharmacopoeia 2005 edition, USP 30 version and version 6 of the European Pharmacopoeia standards of cisplatin, carboplatin and other platinum anti-cancer ingredients Drug production line, for the enterprise toward the nation's largest platinum anti-tumor drug production base of raw materials towards goal and played a positive role in promoting strong.
KUNMING GUIYAN PHARMACEUTICAL CO.,LTD.,as holder of the certificate of suitability R0-CEP 2009-383-Rev 00 for CARBOPLATIN.